Ohio's Board of Pharmacy Revoked Med Spa Licenses Over Compounded GLP-1s: What Clinics Should Take From It
A May 2025 report said Ohio's Board of Pharmacy revoked four med spa licenses over compounded semaglutide and tirzepatide, and that the attorney general warned 14 more med spas. Here is what the episode signals.
Key Highlights
- According to a May 2025 report, the Ohio Board of Pharmacy revoked four med spa licenses over compounded semaglutide and tirzepatide, and the attorney general warned 14 med spas.
- The action centered on unsafe handling of compounded weight-loss medication, a pharmacy-board issue as much as a medical-board one.
- Ohio is a corporate-practice state, and clinics there face scrutiny from several regulators at once.
- The practical lesson is to source compounded drugs only from compliant pharmacies, keep records, and make sure a physician's prescriptions and protocols match what the clinic actually dispenses.
What Was Reported
A May 2025 news report described action by the Ohio Board of Pharmacy against med spas for potentially unsafe handling of weight-loss medication. According to that report, the board revoked four med spa licenses over compounded semaglutide and tirzepatide, and the Ohio attorney general sent warnings to 14 med spas. The details of each case are in the board's own records; this post relies on the news summary.
Why It Matters Beyond Ohio
The episode shows that enforcement does not only come from the medical board. A pharmacy board can act on how drugs are sourced, stored, dispensed and labeled, and an attorney general can act on how clinics advertise and describe what they sell. A clinic that has a good medical director relationship and a solid entity structure can still be exposed on the drug-handling side.
What Ohio Clinics Should Check
- Where the drug comes from: Compounded GLP-1s should come from a licensed pharmacy filling a patient-specific prescription, not from an unverified source.
- What is on the label and in the ad: Claims such as same active ingredient as a brand-name drug draw regulatory attention, and brand names should not be used for compounded drugs.
- Whether the paperwork matches the product: Prescriptions, protocols and inventory records should describe the same drug, strength and source.
- Who is supervising: A licensed physician's standing orders and chart review should cover the program in practice, not just on paper.
Structure Still Matters
Ohio is a corporate-practice state, and standardizing on a physician-owned PC and a flat, fair-market management fee is the safer design wherever enforcement is less than bright-line. Our Ohio guides cover the structure; this episode is a reminder that compliance in a med spa has more than one regulator.
Disclaimer
This article is general educational information, not legal advice. State law changes and depends on the facts of a clinic's structure, so confirm the specifics with health care regulatory counsel in the state before you rely on them.
MedGrid MSO provides management services to independently owned practices; it does not practise medicine and does not direct clinical decisions. Requirements vary by state and by service, and change over time — nothing on this page is legal or medical advice. Talk to us or your own counsel before making a structural decision for your clinic.